A study is conducted to determine whether a new cancer drug increases the mean survival time by at least 30 days for a certain type of cancer. Explain in context the conclusion of the test if you fail to reject H0. We did not find data support for the claim that the drug increases mean survival time by at least 30 days. We conclude that mean survival time has increased by at least 30 days. The drug was shown to increase mean survival time by at least 30 days. The P-value was too small to conclude that mean survival time has increased by at least 30 days